202 related articles for article (PubMed ID: 35655783)
1. Tofacitinib Downregulates TNF and Poly(I:C)-Dependent MHC-II Expression in the Colonic Epithelium.
Gopalakrishnan S; Hansen MD; Skovdahl HK; Roseth IA; van Beelen Granlund A; Østvik AE; Bakke I; Sandvik AK; Bruland T
Front Immunol; 2022; 13():882277. PubMed ID: 35655783
[TBL] [Abstract][Full Text] [Related]
2. The JAK-Inhibitor Tofacitinib Rescues Human Intestinal Epithelial Cells and Colonoids from Cytokine-Induced Barrier Dysfunction.
Sayoc-Becerra A; Krishnan M; Fan S; Jimenez J; Hernandez R; Gibson K; Preciado R; Butt G; McCole DF
Inflamm Bowel Dis; 2020 Feb; 26(3):407-422. PubMed ID: 31751457
[TBL] [Abstract][Full Text] [Related]
3. The JAK Inhibitor Tofacitinib Rescues Intestinal Barrier Defects Caused by Disrupted Epithelial-macrophage Interactions.
Spalinger MR; Sayoc-Becerra A; Ordookhanian C; Canale V; Santos AN; King SJ; Krishnan M; Nair MG; Scharl M; McCole DF
J Crohns Colitis; 2021 Mar; 15(3):471-484. PubMed ID: 32909045
[TBL] [Abstract][Full Text] [Related]
4. Activation of Epithelial Signal Transducer and Activator of Transcription 1 by Interleukin 28 Controls Mucosal Healing in Mice With Colitis and Is Increased in Mucosa of Patients With Inflammatory Bowel Disease.
Chiriac MT; Buchen B; Wandersee A; Hundorfean G; Günther C; Bourjau Y; Doyle SE; Frey B; Ekici AB; Büttner C; Weigmann B; Atreya R; Wirtz S; Becker C; Siebler J; Neurath MF
Gastroenterology; 2017 Jul; 153(1):123-138.e8. PubMed ID: 28342759
[TBL] [Abstract][Full Text] [Related]
5. Intestinal Epithelial Cells Express Immunomodulatory ISG15 During Active Ulcerative Colitis and Crohn's Disease.
Østvik AE; Svendsen TD; Granlund AVB; Doseth B; Skovdahl HK; Bakke I; Thorsvik S; Afroz W; Walaas GA; Mollnes TE; Gustafsson BI; Sandvik AK; Bruland T
J Crohns Colitis; 2020 Jul; 14(7):920-934. PubMed ID: 32020185
[TBL] [Abstract][Full Text] [Related]
6. TNF-α synergises with IFN-γ to induce caspase-8-JAK1/2-STAT1-dependent death of intestinal epithelial cells.
Woznicki JA; Saini N; Flood P; Rajaram S; Lee CM; Stamou P; Skowyra A; Bustamante-Garrido M; Regazzoni K; Crawford N; McDade SS; Longley DB; Aza-Blanc P; Shanahan F; Zulquernain SA; McCarthy J; Melgar S; McRae BL; Nally K
Cell Death Dis; 2021 Sep; 12(10):864. PubMed ID: 34556638
[TBL] [Abstract][Full Text] [Related]
7. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
Pedersen G
Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
[TBL] [Abstract][Full Text] [Related]
8. Tofacitinib Reprograms Human Monocytes of IBD Patients and Healthy Controls Toward a More Regulatory Phenotype.
Cordes F; Lenker E; Spille LJ; Weinhage T; Bettenworth D; Kessel C; Schmidt HH; Foell D; Varga G
Inflamm Bowel Dis; 2020 Feb; 26(3):391-406. PubMed ID: 31560043
[TBL] [Abstract][Full Text] [Related]
9. Patient Derived Colonoids as Drug Testing Platforms-Critical Importance of Oxygen Concentration.
Skovdahl HK; Gopalakrishnan S; Svendsen TD; Granlund AVB; Bakke I; Ginbot ZG; Thorsvik S; Flatberg A; Sporsheim B; Ostrop J; Mollnes TE; Sandvik AK; Bruland T
Front Pharmacol; 2021; 12():679741. PubMed ID: 34054553
[TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system promotes colonic inflammation by inducing T
He L; Du J; Chen Y; Liu C; Zhou M; Adhikari S; Rubin DT; Pekow J; Li YC
Am J Physiol Gastrointest Liver Physiol; 2019 Jun; 316(6):G774-G784. PubMed ID: 30995068
[TBL] [Abstract][Full Text] [Related]
11. Leaky gut model of the human intestinal mucosa for testing siRNA-based nanomedicine targeting JAK1.
Hartwig O; Loretz B; Nougarede A; Jary D; Sulpice E; Gidrol X; Navarro F; Lehr CM
J Control Release; 2022 May; 345():646-660. PubMed ID: 35339579
[TBL] [Abstract][Full Text] [Related]
12. Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease.
Coskun M; Salem M; Pedersen J; Nielsen OH
Pharmacol Res; 2013 Oct; 76():1-8. PubMed ID: 23827161
[TBL] [Abstract][Full Text] [Related]
13. Impaired IFN-γ-dependent STAT3 Activation Is Associated With Dysregulation of Regulatory and Inflammatory Signaling in Monocytes of Ulcerative Colitis Patients.
Cordes F; Lenker E; Weinhage T; Spille LJ; Bettenworth D; Varga G; Schmidt HH; Foell D
Inflamm Bowel Dis; 2021 May; 27(6):887-901. PubMed ID: 33165509
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive protocols for culturing and molecular biological analysis of IBD patient-derived colon epithelial organoids.
Gopalakrishnan S; Bakke I; Hansen MD; Skovdahl HK; Granlund AVB; Sandvik AK; Bruland T
Front Immunol; 2023; 14():1097383. PubMed ID: 36911731
[TBL] [Abstract][Full Text] [Related]
15. Ubiquitin D is Upregulated by Synergy of Notch Signalling and TNF-α in the Inflamed Intestinal Epithelia of IBD Patients.
Kawamoto A; Nagata S; Anzai S; Takahashi J; Kawai M; Hama M; Nogawa D; Yamamoto K; Kuno R; Suzuki K; Shimizu H; Hiraguri Y; Yui S; Oshima S; Tsuchiya K; Nakamura T; Ohtsuka K; Kitagawa M; Okamoto R; Watanabe M
J Crohns Colitis; 2019 Mar; 13(4):495-509. PubMed ID: 30395194
[TBL] [Abstract][Full Text] [Related]
16. The Viral Mimetic Polyinosinic:Polycytidylic Acid Alters the Growth Characteristics of Small Intestinal and Colonic Crypt Cultures.
Davies JM; Santaolalla R; von Furstenberg RJ; Henning SJ; Abreu MT
PLoS One; 2015; 10(9):e0138531. PubMed ID: 26414184
[TBL] [Abstract][Full Text] [Related]
17. The Janus kinase inhibitor tofacitinib inhibits TNF-α-induced gliostatin expression in rheumatoid fibroblast-like synoviocytes.
Kawaguchi Y; Waguri-Nagaya Y; Tatematsu N; Oguri Y; Kobayashi M; Nozaki M; Asai K; Aoyama M; Otsuka T
Clin Exp Rheumatol; 2018; 36(4):559-567. PubMed ID: 29352846
[TBL] [Abstract][Full Text] [Related]
18. JAK inhibitors: current position in treatment strategies for use in inflammatory bowel disease.
Hernandez-Rocha C; Vande Casteele N
Curr Opin Pharmacol; 2020 Dec; 55():99-109. PubMed ID: 33207299
[TBL] [Abstract][Full Text] [Related]
19. Tofacitinib, the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis.
Palasik BN; Wang H
J Pharm Pract; 2021 Dec; 34(6):913-921. PubMed ID: 32873116
[TBL] [Abstract][Full Text] [Related]
20. Colonoids From Patients With Pediatric Inflammatory Bowel Disease Exhibit Decreased Growth Associated With Inflammation Severity and Durable Upregulation of Antigen Presentation Genes.
Kelsen JR; Dawany N; Conrad MA; Karakasheva TA; Maurer K; Wei JM; Uman S; Dent MH; Behera R; Bryant LM; Ma X; Moreira L; Chatterji P; Shraim R; Merz A; Mizuno R; Simon LA; Muir AB; Giraudo C; Behrens EM; Whelan KA; Devoto M; Russo PA; Andres SF; Sullivan KE; Hamilton KE
Inflamm Bowel Dis; 2021 Jan; 27(2):256-267. PubMed ID: 32556182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
